Abstract
Because of the typical metaphyseal-epiphyseal growth of giant cell tumors and chondroblastomas, the optimal result of an en bloc resection can usually only be achieved by a loss of joint function. For this reason, intralesional excision has prevailed, though it leads to a high rate of relapses. Adjuvant therapy involving irrigation of the remaining bone cavity with phenol can distinctly decrease the rate of relapse. Little is known about the amount of phenol applied that is absorbed. This study investigated the urinary excretion of phenol following the instillation of 102 ml of a 5% phenol solution. The method consisted of urine collection from 11 patients treated by phenol instillation preoperatively, and at 1, 3, 6, 12 and 24 h postoperatively. The urine specimens were analysed for phenol by mass spectrometry. Preoperatively, the value was 5.1 mg/l on average. The maximum concentration of 62 mg/l was found 1 h after instillation, with an average value of 41.5 mg/l, and after 3 h of 18.9 mg/l. A further rapid decrease in the excretion rate was recorded, with normal values being reached after 12 h. This means a maximum of 9% and an average of 2% of the instilled amount of phenol were excreted in the urine within 24 h postoperatively. By comparing these urinary concentrations to published standards, we conclude that the instillation of a 5% phenol solution into bony lesions is associated with a relatively low risk of systemic toxicity.
Similar content being viewed by others
References
Campanacci M, Giunti A, Olmi R (1975) Giant-cell tumors of bone. A study of 209 cases with long term follow up in 130. Ital J Orthop Traumatol 1: 249
Campanacci M, Baldini N, Boriani S, Sudanese A (1987) Giant-cell tumors of bone. J Bone Joint Surg [Am] 69: 106–114
Capanna R, Fabbri N, Betelli G (1990) Curettage of giant cell tumor of bone. The effect of surgical technique and adjuvants on local recurrence rate. Chir Organi Mov 75 [Suppl]: 206–214
Carnesal PG (1992) Sometimes malignant tumors of bone. Campbell's operative orthopaedics, Vol 1, 8th edn. Mosby, St. Louis, pp 253–255
Daunderer M (1989) Klinische Toxikologie. (Ecomed Verlagsgesellschaft mbH 47) Erg.-Lfg. 10.
Deichmann WB, Keplinger ML (1981) Phenols and phenolic compounds. In: Fassett DW, Irish DD (eds) Toxicology, Vol. 2 A. (Industrial hygiene and toxicology, 3rd edn) Interscience, New York, pp 2567–2584
Deutsches Arzneimittelbuch (1988) DAB 9, 9th edn. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 2733–2737
Eckardt JJ, Grogan TJ (1986) Giant cell tumor of bone. Clin Orthop 204: 45–58
Enneking WF (1983) Musculoskeletal surgery Churchill Livingstone, New York.
Greim H, Lehnert G (1990) Biologische Arbeitsstoff-Toleranz-Werte (BAT-Werte) and Expositionsaquivalente für krebserzeugende Arbeitsstoffe (EKA). VCH Verlag, Vol 1. DFG
Hill AE, Malisoff WM (1926) Phasendiagramm Phenol/Wasser. J Am Chem Soc 48: 923
Kerschbaumer FW, Russe R, Bauer R (1984) Grundlagen der Kryochirurgie in der Orthopädie. Orthopäde 13: 133–141
Kotz R, Salzer-Kunschik M, Lechner G, Immenkamp M (1984) Tumoren und tumorähnliche Erkrankungen der Knochen und der Weichteile. In: Witt AN, Rettig H, Schlegel KF, Hackenbroch M, Hupfauer W (eds) Orthopädie in Praxis and Klinik, Vol III. Thieme, Stuttgart
List PH (1985) Arzneiformenlehre. Ein Lehrbuch fur Pharmazeuten, 4. Aufl. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 85–90
Marcove RC (1982) A l7-year review of cryosurgery in the treatment of bone tumors. Clin Orthop 163: 231–234
National Institute for Occupational Safety and Health, U.S. Department of Health, Education and Welfare (1976) Criteria for a recommended standard. Occupational exposure to phenol. (NIOSH 76-196) US Government Printing Office, Washington, DC, pp 23–69
Ogata M, Yamasaki Y, Kawai T (1986) Significance of urinary phenyl sulfate and phenylglucuronide as indices of exposure to phenol. Int Arch Occup Environ Health 58: 197–202
Persson BM, Wouters HW (1976) Curettage and acrylic cementation in surgery of giant cell tumors of bone. Clin Orthop 120: 125
Piotrowski JK (1971) Evaluation of exposure to phenol: absorption of phenol vapour in the lungs and through the skin and excretion of phenol in urine. Br J Ind Med 28: 172–178
Quint U, Vanhöfer J, Harstrick A, Müller RT (1996) Cytotoxicity of phenol to musculoskeletal tumors. J Bone Joint Surg [Br] 78:984–985
Reynolds JEF (1993) Martindale The Extra Pharmacopoeia, 30th edn. The pharmaceutical press, London, pp 570–572
Schiller C, Ritschl P, Windhager R, Kropej D, Kotz R (1989) Die Rezidivhaufigkeit phenolisierter und nicht phenolisierter Knochenhöhlen nach intraläsionaler Resektionen nicht maligner Knochentumoren. Z Orthop 127: 398–401
Sherwood RJ (1972) Benzene. The interpretation of monitoring results. Ann Occup Hyg 15: 409–421
Sherwood RJ, Carter FWG (1970) The measurement of occupational exposure to benzene vapour. Ann Occup Hyg 13: 125–146
Szendröi M (1992) Adjuvante Therapie (Phenol, Knochenzement) bei den Riesenzelltumoren. Z Orthop 130: 95–98
Wengle B, Hellstom K (1972) Volatile phenols in serum of uraemic patients. Clin Sci 43: 493–498
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Quint, U., Müller, R.T. & Müller, G. Characteristics of phenol. Arch Orthop Trauma Surg 117, 43–46 (1998). https://doi.org/10.1007/BF00703438
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00703438